Abstract
Purpose
The purpose of this study was to investigate the risk factors associated with post-extraction persistent bleeding in patients on warfarin or direct-acting oral anticoagulants (DOACs) and the ability of risk scores to predict post-extraction bleeding.
Methods
Three hundred ninety-one patients taking warfarin or DOACs underwent tooth extractions. Various risk factors for post-extraction bleeding, including number of tooth extraction, with antiplatelet therapy, and risk scores, were investigated by univariate and multivariate analyses. A post-extraction bleeding was classified into grades 1–3.
Results
The incidence of post-extraction bleeding was 26.8% (77 out of 287 patients; grade 1: 63, grade 2:14) in patients taking warfarin, and 26.0% (27 out of 104 patients; grade 1: 20, grade 2:7) in patients taking warfarin DOACs. Multivariate analyses showed that multiple teeth extractions and HAS-BLED scores (above 3 points) in patients taking warfarin, and only multiple teeth extractions in patients taking DOAC, were significantly associated with post-extraction bleeding, respectively.
Conclusion
Most of the post-extraction bleedings were grade 1, which can be stopped by eligibly pressing gauze by surgeons. If patients taking anticoagulants are scheduled to undergo multiple teeth extractions or their HAS-BLED score are above 3 points (if warfarin), we recommend informing patients risk of post-extraction bleeding before operation, taking carefully hemostasis, and instructing patients to bite down accurately on the gauze for longer than usual.
Similar content being viewed by others
References
Perry DJ, Noakes TJ, Helliwell PS (2007) Guideline for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J 203:389–393
Becci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M, Zanon E (2010) Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, muiticentre, prospective, case-control study. Thromb Haemost 104:972–975
Aframian DJ, Lalla RV, Peterson DE (2007) Management of dental patients taking common hemostasis-altering medications. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 103:e1-11
Guidelines for Diagnosis and Treatment of Cardiovascular Disease (2008 Joint Working Groups Report). Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease (JCS 2009). http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf (available in December 2015, in Japanese)
JCS Joint Working Group (2014) Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J 78:1997–2021
Mauprivez C, Khonsari RH, Razouk O, Goudot P, Lesclous P, Descroix V (2016) Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 122:e146-155
Yoshikawa H, Yoshida M, Yasaka M, Yoshida H, Murasato Y, Fukunaga D, Shintani A, Okada Y (2019) Safety of tooth extraction in patients receiving direct oral anticoagulant treatment versus warfarin: a prospective observation study. Int J Oral Maxillofac Surg 48:1102–1108
Evans IL, Sayers MS, Gibbons AJ, Price G, Snooks H, Sugar AW (2002) Can warfarin be continued during dental extraction? Results of randomized controlled trial. Br J Oral Maxillofac Surg 40:248–252
Zanon E, Martinelli F, Bacci C, Cordioli G, Girolami A (2003) Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis 14:27–30
Cannon PD, Dharmar VT (2003) Minor oral surgical procedures in patients on oral anticoagulants—a controlled study. Aust Dent J 48:115–118
Sacco R, Sacco M, Carpenedo M, Mannucci PM (2007) Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different intensity targets. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:e18-21
Morimoto Y, Niwa H, Minematsu K (2008) Hemostatic management of tooth extractions in patients on oral antithrombotic therapy. J Oral Maxillofac Surg 66:51–57
Morimoto Y, Niwa H, Yoneda T, Motomura K, Yasaka M, Minematsu K (2004) Hemostatic management of tooth extraction in patients undergoing antithrombotic therapy. Jpn Stomatol Soc 53:74–80
Shigeta T, Umeda M, Yoshitake M, Takahashi H, Shibuya Y, Komori T, Ido S, Hasegawa T, Ri S (2012) A clinical study of hemorrhagic complications in patients with antithrombotic therapy who underwent dental extraction without discontinuation of antithrombotic drugs: 282 patients receiving administration of warfarin. Jpn Stomatol Soc 61:1–7
Hughes M, Lip GY, Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2007) Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM 100:599–607
Palareti G, Cosmi B (2009) Bleeding with anticoagulation therapy—who is at risk, and how best to identify such patients. Thromb Haemost 102:268–278
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–1100
Kataoka T, Hoshi K, Ando T (2016) Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study. BMJ Open 6:e010471
Japanese Society of Oral and Maxillofacial Surgeons, Japanese Society of Gerodontology, Japanese Society of Dentistry for medically compromised patient (2015) Guidelines for patients on antithrombotic therapy requiring dental extraction. Gakujutsusha Corporation, Tokyo
Inoue K, Hirao K, Aonuma K, Kumagai K, Kimura M, Miyauchi Y, Tsushima E, Okumura K, JACRE Investigators (2020) HAS-BLED score as a predictor of bleeding complications from catheter ablation of atrial fibrillation: a subanalysis of the Japanese anti-coagulation regimen exploration in AF catheter ablation registries. J Cardiol 75:82–89
Okumura K, Aonuma K, Kumagai K, Hirao K, Inoue K, Kimura M, Miyauchi Y, Tsushima E, JACRE Investigators (2016) Efficacy and safety of rivaroxaban and warfarin in the perioperative period of catheter ablation for atrial fibrillation-outcome analysis from a prospective multicenter registry study in Japan. Circ J 80:11
Samama MM, Contant G, Spiro TE, Perzborn E, Le Flem L, Guinet C, Gourmelin Y, Rohde G, Martinoli JL (2013) Laboratory assessment of rivaroxaban: a review. Thrombosis J 11:11
Samama MM, Guinet C (2011) Laboratory assessment of new anticoagulants. Clin Chem Lab Med 49:761–772
Hillarp A, Baghaei F, Fagerberg Blixter I, Gustafsson KM, Stigendal L, Sten-Linder M, Strandberg K, Lindahl TL (2011) Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost 9:133–139
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, ESC Scientific Document Group (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962
BCGuidelines.ca: Warfarin therapy – management during invasive procedures and surgery (2015). https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/warfarin-during-surgery.
Author information
Authors and Affiliations
Contributions
Study design: E Iwata
Acquisition of data: E Iwata, R Kadoya, Y Enomoto
Analysis and interpretation of data: E Iwata, A Tachibana, M Akashi
Manuscript preparation: E Iwata, A Tachibana, J Kusumoto, T Hasegawa, R Kadoya, Y Enomoto, N Takata, M Akashi
Manuscript editing: E Iwata, M Akashi
Manuscript review: E Iwata, A Tachibana, J Kusumoto, T Hasegawa, R Kadoya, Y Enomoto, N Takata, M Akashi
Statistical analysis: E Iwata, A Tachibana, J Kusumoto, M Akashi
Corresponding author
Ethics declarations
Ethical approval
This retrospective study has been conducted in full accordance with the World Medical Association Declaration of Helsinki and was approved by the Ethical Committee of Kakogawa Central City Hospital approved the study design (authorization number: 2019–84).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Iwata, E., Tachibana, A., Kusumoto, J. et al. Risk factors associated with post-extraction bleeding in patients on warfarin or direct-acting oral anticoagulants: a retrospective cohort study. Oral Maxillofac Surg 26, 641–648 (2022). https://doi.org/10.1007/s10006-022-01039-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-022-01039-0